Tamoxifen and Megestrol Acetate for Postmenopausal Breast Cancer: Diverging Effects on Liver Proteins, Androgens, and Glucocorticoids

Autor: Birgitta Wallberg, Lars-Erik Rutqvist, Tommy Fornander, B. von Schoultz, E. von Schoultz, L. Löfgren, K. Carlström, N. Wilking
Rok vydání: 2004
Předmět:
Zdroj: Medical Oncology. 21:309-318
ISSN: 1357-0560
Popis: Aim To compare the effects of tamoxifen and megestrol acetate on liver proteins, androgens, and glucocorticoids during adjuvant treatment for postmenopausal breast cancer. Methods A subgroup of women within a large prospective multicenter trial were followed with blood sampling every 3 mo during 2 yr. Women were randomized to receive either continuous tamoxifen 40 mg/d or repeated sequential treatment with tamoxifen and megestrol acetate (MA) 160 mg/d. Results We found profound and distinct differences between the two regimens. Tamoxifen increased steroid-binding proteins (SHBG and CBG) and suppressed circulating androgens and IGF-I. In contrast, the metabolic effects of tamoxifen were clearly antagonized by MA. There was a rise in IGF-I and marked suppression of steroid-binding proteins. Levels of free testosterone were reduced by 70%. MA also caused apparent adrenal suppression. Conclusion The different effects on anabolic/catabolic balance and adrenal function may relate to certain clinical effects during treatment.
Databáze: OpenAIRE